LearnGlossaryMarketStocksSuperinvestorsSign in

ATEC

Alphatec Holdings, Inc.

Healthcare · $1.6B market cap

Verdict

We can't put a fair value on ATEC right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-25.3% a year✗
Sales growth9.3% a year✗
Free cash flow growth-3.4% a year✗
Return on invested capital-20.3%✗

Follow ATEC

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

2 of the investors we track hold ATEC. In Q2 2026, 1 opened a position and 1 added. Who we track

Howard Marks

Oaktree Capital Management · as of Q2 2026

$9.1B

9,177,000 shares

First Eagle Investment Management

First Eagle Investment Management · as of Q2 2026

$8.6M

996,637 shares

Moves in Q2 2026

New position: Howard Marks

Added: First Eagle Investment Management

Insider activity

Since Sep 10, 2026: 1 open-market purchase worth $1.0M. Why purchases matter

Purchases

Miles Patrick

CEO · 2026-09-10

Bought

$1.0M

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works